Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink [NA]

View source ↗

Summary

A multi-center clinical trial is evaluating the lipid-lowering efficacy and safety of Menggongzi Tibetan Tea Special Drink for hyperlipidemias. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Menggongzi Tibetan Tea Special Drink

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Hyperlipidemias | NA | Status: NOT_YET_RECRUITING